过敏性结膜炎的过敏原免疫治疗机制及疗效的研究进展

Research progress of allergen immunotherapy mechanism and efficacy of allergic conjunctivitis

过敏性结膜炎是过敏性眼病最常见的类型,尤其儿童、青少年发病率逐年上升。药物治疗仅能对部分过敏性结膜炎有效,且只能短期内缓解症状,而过敏原免疫治疗是一种有效的治疗方法,可以显著改善慢性过敏的症状以及疾病的发病病程。该方法在国外已经应用多年,但在我国尚未见报道。文章将对该治疗方法的有效性机制及几种免疫治疗方法的临床疗效进行综述,为其下一步在我国的临床应用提供参考。

Allergic conjunctivitis is the most common type of allergic eye disease,and the incidence in children and adolescents is increasing year by year.Drug therapy can only relieve some symptoms and only in a short period,while allergen immunotherapy is currently a therapy that can significantly improve the symptoms of chronic allergy and the course of the disease.This method has been used abroad for many years but has yet to be reported in China.The author reviews the effective mechanism and clinical efficiency of allergen immunotherapy and provides a reference for the further clinical application in China.